Pharmaceutical Advisors
About UsOur FocusCase StudiesAdvisor TeamsDownloadsEventsContact Us

Case Studies

Interpret Complex Toxicology and CMC Risks in Order to Move Forward


Our client's lead drug candidate was threatened by evidence of cardio-tox issues.


The Pharmaceutical Advisors team provided a rapid review of the data, identified the risks and non-issues and recommended additional tests to enable getting into man. A parallel process chemistry review identified polymorph and scalability issues requiring more work on the final salt form BEFORE doing any more tox studies.


The lead candidate continues in development and roughly $400,000 in expense and nine months of lost time-to-market were avoided.

Click here to see information on the Advisors Team that helped this client.